Chronic disease management vs usual care
Self‐efficacy · adults with asthma
1 finding from 1 review
- no estimate extracted5 studies · 642 participantsLow
Findings
What do systematic reviews say?
3,006 questions · 3,171 findings · 607 reviews · Headline outcomes only
No studies found 411 · 13%GRADE not reported 153 · 4.8%Very low 968 · 30.5%Low 897 · 28.3%Moderate 589 · 18.6%High 153 · 4.8%
Chronic disease management vs usual care
Asthma severity score5 Measured on different scales in different studies. Higher scores indicate lower severity · adults with asthma
1 finding from 1 review
- no estimate extracted6 studies · 1330 participantsLow
Intervention not reported
Health‐related quality of life (cough‐specific) Leicester Cough Questionnaire Scale from 0 to 133; higher score indicates better HRQoL. Contains 19 questions from 3 domains on a Likert scale · individuals with stable bronchiectasis
1 finding from 1 review
- no estimate extracted1 study · 20 participantsLow
Intervention not reported
Health‐related quality of life (health status) COPD Assessment Tool. Scale from 0 to 5; higher score indicates worse HRQoL Contains 10 questions with 5‐point Likert scale · individuals with stable bronchiectasis
The intervention showed no clear difference in health‐related quality of life (health status) COPD Assessment Tool.… (low certainty).
1 finding from 1 review
- no estimate extracted1 study · 30 participantsLow
Lidocaine vs disopyramide
Adverse events (AEs; adverse drug reaction): cardiac blocks (high‐degree atrioventricular block and bundle) · patients with myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): cardiac blocks… compared with disopyramide (very low certainty).
1 finding from 1 review
- RR 0.57 [0.15, 2.18]1 study · 68 participantsVery low
Morita therapy plus pharmacological therapy vs Pharmacological therapy
Anxiety · patients with anxiety disorders
1 finding from 1 review
- no estimate extracted1 study · 103 participantsVery low
Morita therapy plus pharmacological therapy vs Pharmacological therapy
Mean depression scores ‐ HAMD · patients with anxiety disorders
1 finding from 1 review
- no estimate extracted1 study · 56 participantsVery low
Morita therapy plus pharmacological therapy vs Pharmacological therapy
Measures of obsession and compulsion overall mean endpoint score of Y‐BOCS (high = poor) · patients with anxiety disorders
1 finding from 1 review
- no estimate extracted2 studies · 159 participantsVery low
Morita therapy vs Pharmacological therapy
Anxiety · people with social phobia
1 finding from 1 review
- no estimate extracted1 study · 39 participantsVery low
Morita therapy vs Pharmacological therapy
Depression at endpoint · people with social phobia
1 finding from 1 review
- no estimate extracted1 study · 39 participantsVery low
Intervention not reported
Live birth or ongoing pregnancy Low dose vaginal vs high dose vaginal · subfertile women
The intervention showed no clear difference in live birth or ongoing pregnancy Low dose vaginal vs high dose vaginal (moderate certainty).
1 finding from 1 review
- OR 0.97 [0.84, 1.11]5 studies · 3720 participantsModerate
Intervention not reported
OHSS Low dose vaginal vs high dose vaginal · subfertile women
The intervention showed no clear difference in OHSS Low dose vaginal vs high dose vaginal (low certainty).
1 finding from 1 review
- OR 0.91 [0.57, 1.46]2 studies · 1251 participantsLow
Intervention not reported
Live birth/ongoing pregnancy ‐ low vs high dose protocol · subfertile women
It is very uncertain whether the intervention changes live birth/ongoing pregnancy ‐ low vs high dose protocol (very low certainty).
1 finding from 1 review
- OR 0.65 [0.37, 1.13]1 study · 285 participantsVery low
Intervention not reported
OHSS ‐ low vs high dose protocol · subfertile women
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Intervention not reported
ADAS‐Cog Scale from: 1 to 70 (higher scores represent worse performance) · patients with Alzheimer's disease
1 finding from 1 review
- no estimate extracted3 studies · 1243 participantsLow
Intervention not reported
MMSE Scale from: 0 to 30 (higher scores represent better performance) · patients with Alzheimer's disease
1 finding from 1 review
- no estimate extracted3 studies · 1243 participantsLow
Intervention not reported
ADCS‐ADL Scale from: 0 to 54 (higher scores represent better performance) · patients with Alzheimer's disease
1 finding from 1 review
- no estimate extracted3 studies · 1243 participantsLow
Intervention not reported
NPI Scale from: 0 to 144 (higher scores represent worse performance) · patients with Alzheimer's disease
1 finding from 1 review
- no estimate extracted3 studies · 1243 participantsHigh
Long‐acting FSH (all doses) vs daily FSH
Live birth rate
It is very uncertain whether long‐acting FSH (all doses) changes live birth rate ‐ High dose (240 μg) compared with daily FSH (very low certainty).
1 finding from 1 review
- Long‐acting FSH versus daily FSH for women undergoing assisted reproduction 2015 · Cochrane Headline outcomes onlyRR 0.43 [0.12, 1.52]1 study · 33 participantsVery low
Long‐acting FSH (all doses) vs daily FSH
OHSS ‐ High dose (240 μg)
It is very uncertain whether long‐acting FSH (all doses) changes OHSS ‐ High dose (240 μg) compared with daily FSH (very low certainty).
1 finding from 1 review
- Long‐acting FSH versus daily FSH for women undergoing assisted reproduction 2015 · Cochrane Headline outcomes onlyRR 1.73 [0.09, 32.75]1 study · 33 participantsVery low